Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but ...

El-Khoueiry, MD, an associate professor of clinical medicine in the Division of Medical Oncology and director of the phase I ...

The type of provider treating a patient with menopause symptoms significantly impacted the patient’s chances of receiving a ...

The FDA has proposed removing the black box warning for menopausal hormone therapy, focusing on local estrogen use and ...

GrayOS, developed by Gray Oncology Solutions, is being implemented at CancerCare Manitoba (CCMB) to enhance access to systemic therapy and improve efficiency in cancer ...

On October 8, 2025, the US FDA approved the immunotherapy cemiplimab-rwlc (Libtayo) for adjuvant treatment of adult patients ...

FDA-approved indications for hormone therapy include moderate to severe VMS, prevention of osteoporosis, and management of premature menopause or early estrogen deficiency. Indirect benefits may ...

VCN-01 plus standard chemotherapy and Abraxane proved safe and effective for patients with metastatic pancreatic cancer.

Not all health care professionals receive the same type of formal education. That may help explain the results of a new study ...

An expert discusses how underutilization of combination lipid-lowering therapies stems from overly complex guidelines, primary care providers managing multiple chronic diseases simultaneously, cost ...

Yulia Abramova’s work exemplifies the next evolution of psychotherapy — one that bridges science and soul, mind and body, East and West. Her Generative Attachment Model not only redefines trauma ...